CASP3 and colorectal carcinoma: High CK18 levels and high Caspase-3 activity were also associated with shorter disease-free progression in these patients.29 Taken together, these data present evidence pointing to Caspase-3 as a potential predictive biomarker of response to 5FU-based CT in advanced CRC.